Symbols / DYAI $0.83 +1.22% Dyadic International, Inc.

Healthcare • Biotechnology • United States • NCM
DYAI Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells industrial enzymes and other proteins in the United States and internationally. It utilizes the C1 platform in pharmaceutical applications, including the development and production of pharmaceutical products. The company offers Dapibus, a protein production platform that enable the rapid development and large-scale manufacture of cost-effective enzymes, proteins, metabolites, and other biologic products for life sciences, food and nutrition, and bioindustrial applications. In addition, it develops DYAI-100, a C1-SARS-CoV-2 recombinant protein RBD vaccine candidate and first C1, which is in phase 1 clinical trial to produce protein tested in humans. The company has a research and development agreement with VTT Technical Research Centre of Finland, Ltd.; license agreement with South Africa's Rubic One Health; joint development agreement with a Global Food Ingredient Company; and sub-license agreement with Abic Biological Laboratories Ltd., Alphazyme, LLC, and Abic Biological Laboratories Ltd. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida.

Fundamentals
Scroll to Statements
Market Cap 30.24M Enterprise Value 27.98M Income -7.36M Sales 3.09M Book/sh 0.03 Cash/sh 0.20
Dividend Yield — Payout 0.00% Employees — IPO — P/E — Forward P/E -2.59
PEG — P/S 9.79 P/B 24.41 P/C — EV/EBITDA — EV/Sales 9.05
Quick Ratio 2.29 Current Ratio 2.68 Debt/Eq 410.63 LT Debt/Eq — EPS (ttm) -0.23 EPS next Y -0.32
EPS Growth — Revenue Growth -30.80% Earnings 2026-05-13 ROA -44.94% ROE -3.98% ROIC —
Gross Margin 24.93% Oper. Margin -269.65% Profit Margin -238.31% Shs Outstand 36.44M Shs Float 30.49M Short Float 0.46%
Short Ratio 1.21 Short Interest — 52W High 1.35 52W Low 0.65 Beta 1.21 Avg Volume 67.95K
Volume 102.16K Target Price $7.00 Recom None Prev Close $0.82 Price $0.83 Change 1.22%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$7.00
Mean price target
2. Current target
$0.83
Latest analyst target
3. DCF / Fair value
$-2.24
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.83
Low
$5.00
High
$9.00
Mean
$7.00

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2024-11-14 reit HC Wainwright & Co. Buy → Buy $6
2024-07-08 reit HC Wainwright & Co. Buy → Buy $6
2023-11-13 reit HC Wainwright & Co. Buy → Buy $6
2023-05-24 reit HC Wainwright & Co. Buy → Buy $6
2023-02-03 reit HC Wainwright & Co. — → Buy $6
2022-07-18 down Dawson James Buy → Neutral —
2022-04-05 main HC Wainwright & Co. — → Buy $6
2021-12-17 init HC Wainwright & Co. — → Buy $7
News
RSS: Latest DYAI news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-01-02 EMALFARB MARK A Chief Executive Officer — 102,609 $0.00 $0
2026-01-02 KAYE JACK Director — 21,552 — —
2026-01-02 LUCY PATRICK K Director — 21,552 — —
2026-01-02 RAWSON PING WANG Chief Financial Officer — 29,158 $0.00 $0
2026-01-02 TCHELET RONEN Officer — 18,064 $0.00 $0
2026-01-02 HERBST SETH J. M.D. Director — 21,552 — —
2026-01-02 HAZELTON JOSEPH P President — 36,418 $0.00 $0
2025-08-01 HAZELTON JOSEPH P President — 26,000 $0.95 $24,700
2025-06-20 TARNOK MICHAEL P Director — 10,776 — —
2025-06-20 BOSE ARINDAM Director — 10,776 — —
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
1.23
-64.74%
3.50
+20.58%
2.90
-1.07%
2.93
Operating Revenue
1.23
-64.74%
3.50
+20.58%
2.90
-1.07%
2.93
Cost Of Revenue
2.32
+94.19%
1.19
-39.54%
1.98
-6.94%
2.12
Reconciled Cost Of Revenue
2.32
+94.19%
1.19
-39.54%
1.98
-6.94%
2.12
Gross Profit
-1.09
-147.27%
2.30
+149.28%
0.92
+14.35%
0.81
Operating Expense
6.06
-25.93%
8.18
-10.26%
9.11
-16.56%
10.92
Research And Development
2.15
+5.40%
2.04
-38.00%
3.30
-26.75%
4.50
Selling General And Administration
5.76
-6.08%
6.13
+5.46%
5.82
-9.41%
6.42
General And Administrative Expense
5.76
-6.08%
6.13
+5.46%
5.82
-9.41%
6.42
Other Gand A
5.76
-6.08%
6.13
+5.46%
5.82
-9.41%
6.42
Other Operating Expenses
-1.86
—
—
—
Total Expenses
8.38
-10.62%
9.37
-15.48%
11.09
-14.99%
13.05
Operating Income
-7.15
-21.57%
-5.88
+28.24%
-8.19
+19.02%
-10.12
Total Operating Income As Reported
-7.19
-21.90%
-5.90
+28.30%
-8.23
+19.04%
-10.17
EBITDA
-6.91
-28.39%
-5.38
+20.81%
-6.80
+32.82%
-10.12
Normalized EBITDA
-6.86
-26.57%
-5.42
+30.27%
-7.77
+22.76%
-10.07
EBIT
-6.91
-28.39%
-5.38
+20.81%
-6.80
+32.82%
-10.12
Total Unusual Items
-0.05
-217.01%
0.04
-95.91%
0.98
+2061.57%
-0.05
Total Unusual Items Excluding Goodwill
-0.05
-217.01%
0.04
-95.91%
0.98
+2061.57%
-0.05
Special Income Charges
0.00
-100.00%
0.06
-93.84%
1.02
0.00
Net Income
-7.36
-26.78%
-5.81
+14.51%
-6.80
+30.20%
-9.74
Pretax Income
-7.36
-26.78%
-5.81
+14.51%
-6.80
+30.20%
-9.74
Net Non Operating Interest Income Expense
-0.17
-692.03%
0.03
-93.04%
0.42
+130.95%
0.18
Interest Expense Non Operating
0.46
+6.53%
0.43
0.00
—
Net Interest Income
-0.17
-692.03%
0.03
-93.04%
0.42
+130.95%
0.18
Interest Expense
0.46
+6.53%
0.43
0.00
—
Interest Income Non Operating
0.28
-37.84%
0.46
+9.67%
0.42
+130.95%
0.18
Interest Income
0.28
-37.84%
0.46
+9.67%
0.42
+130.95%
0.18
Other Income Expense
-0.05
-217.01%
0.04
-95.91%
0.98
+389.39%
0.20
Other Non Operating Income Expenses
—
—
—
0.25
Gain On Sale Of Security
-0.05
-107.88%
-0.02
+41.27%
-0.04
+23.04%
-0.05
Gain On Sale Of Business
0.00
-100.00%
0.06
-93.84%
1.02
0.00
Tax Provision
—
—
—
—
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-7.36
-26.78%
-5.81
+14.51%
-6.80
+30.20%
-9.74
Net Income From Continuing Operation Net Minority Interest
-7.36
-26.78%
-5.81
+14.51%
-6.80
+30.20%
-9.74
Net Income From Continuing And Discontinued Operation
-7.36
-26.78%
-5.81
+14.51%
-6.80
+30.20%
-9.74
Net Income Continuous Operations
-7.36
-26.78%
-5.81
+14.51%
-6.80
+30.20%
-9.74
Normalized Income
-7.32
-25.11%
-5.85
+24.77%
-7.77
+19.73%
-9.69
Net Income Common Stockholders
-7.36
-26.78%
-5.81
+14.51%
-6.80
+30.20%
-9.74
Diluted EPS
—
-0.20
+16.67%
-0.24
+29.41%
-0.34
Basic EPS
—
-0.20
+16.67%
-0.24
+29.41%
-0.34
Basic Average Shares
—
29.32
+1.80%
28.80
+1.53%
28.36
Diluted Average Shares
—
29.32
+1.80%
28.80
+1.53%
28.36
Diluted NI Availto Com Stockholders
-7.36
-26.78%
-5.81
+14.51%
-6.80
+30.20%
-9.74
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
9.95
+0.16%
9.93
+20.82%
8.22
-40.06%
13.71
Current Assets
9.90
+0.70%
9.83
+21.82%
8.07
-39.89%
13.42
Cash Cash Equivalents And Short Term Investments
7.32
-20.97%
9.26
+27.54%
7.26
-42.54%
12.64
Cash And Cash Equivalents
4.62
-28.96%
6.51
-0.13%
6.52
+12.44%
5.79
Cash Equivalents
—
5.58
-14.00%
6.49
+12.51%
5.77
Cash Financial
—
0.93
+3493.74%
0.03
-3.76%
0.03
Other Short Term Investments
2.70
-2.10%
2.76
+268.38%
0.75
-89.07%
6.85
Receivables
1.13
+330.74%
0.26
-45.14%
0.48
+22.65%
0.39
Accounts Receivable
0.49
+180.32%
0.17
-57.63%
0.41
+255.61%
0.12
Other Receivables
0.60
+855.92%
0.06
+13.49%
0.06
-74.11%
0.21
Accrued Interest Receivable
0.04
+44.87%
0.02
+140.48%
0.01
-82.70%
0.06
Prepaid Assets
0.22
-27.72%
0.30
-7.54%
0.33
-16.43%
0.39
Restricted Cash
1.23
0.00
—
—
Other Current Assets
—
0.30
-7.54%
0.33
—
Total Non Current Assets
0.05
-52.17%
0.10
-32.45%
0.15
-47.76%
0.29
Net PPE
0.04
-58.21%
0.09
-34.81%
0.14
0.00
Gross PPE
0.04
-58.21%
0.09
-34.81%
0.14
0.00
Other Properties
0.04
-58.21%
0.09
-34.81%
0.14
—
Investments And Advances
—
—
0.00
-100.00%
0.28
Long Term Equity Investment
—
—
0.00
-100.00%
0.28
Other Non Current Assets
0.01
+1.36%
0.01
-0.63%
0.01
+73.07%
0.01
Total Liabilities Net Minority Interest
8.71
+16.80%
7.46
+218.71%
2.34
-10.84%
2.63
Current Liabilities
3.69
+50.62%
2.45
+8.71%
2.25
-8.04%
2.45
Payables And Accrued Expenses
1.53
+43.58%
1.06
-37.96%
1.71
-23.20%
2.23
Payables
0.85
+76.65%
0.48
-26.53%
0.66
-48.57%
1.28
Accounts Payable
0.85
+76.65%
0.48
-26.53%
0.66
-48.57%
1.28
Current Accrued Expenses
0.67
+16.12%
0.58
-45.07%
1.06
+10.69%
0.96
Pensionand Other Post Retirement Benefit Plans Current
0.40
-20.42%
0.50
—
0.58
Current Debt And Capital Lease Obligation
0.03
-36.18%
0.05
+12.88%
0.05
—
Current Capital Lease Obligation
0.03
-36.18%
0.05
+12.88%
0.05
0.00
Current Deferred Liabilities
1.73
+107.58%
0.83
+70.13%
0.49
+125.64%
0.22
Current Deferred Revenue
—
—
0.00
-100.00%
0.18
Other Current Liabilities
—
0.00
—
—
Total Non Current Liabilities Net Minority Interest
5.03
+0.28%
5.01
+5539.66%
0.09
-49.64%
0.18
Long Term Debt And Capital Lease Obligation
5.03
+0.28%
5.01
+5539.66%
0.09
0.00
Long Term Debt
5.03
+0.98%
4.98
—
—
Long Term Capital Lease Obligation
0.00
-100.00%
0.03
-61.04%
0.09
0.00
Non Current Deferred Liabilities
—
—
0.00
-100.00%
0.18
Non Current Deferred Revenue
—
—
0.00
-100.00%
0.18
Stockholders Equity
1.23
-50.11%
2.47
-57.98%
5.88
-46.98%
11.09
Common Stock Equity
1.23
-50.11%
2.47
-57.98%
5.88
-46.98%
11.09
Capital Stock
0.05
+15.09%
0.04
+2.50%
0.04
+0.61%
0.04
Common Stock
0.05
+15.09%
0.04
+2.50%
0.04
+0.61%
0.04
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
48.44
+15.09%
42.09
+2.50%
41.06
+0.61%
40.82
Ordinary Shares Number
36.19
+21.29%
29.84
+3.56%
28.81
+0.87%
28.56
Treasury Shares Number
12.25
+0.00%
12.25
+0.00%
12.25
+0.00%
12.25
Additional Paid In Capital
113.56
+5.70%
107.44
+2.28%
105.04
+1.53%
103.46
Retained Earnings
-93.45
-8.55%
-86.09
-7.24%
-80.28
-9.25%
-73.48
Treasury Stock
18.93
+0.00%
18.93
+0.00%
18.93
+0.00%
18.93
Total Equity Gross Minority Interest
1.23
-50.11%
2.47
-57.98%
5.88
-46.98%
11.09
Total Capitalization
6.26
-15.97%
7.45
+26.69%
5.88
-46.98%
11.09
Working Capital
6.21
-15.86%
7.38
+26.90%
5.82
-47.00%
10.97
Invested Capital
6.26
-15.97%
7.45
+26.69%
5.88
-46.98%
11.09
Total Debt
5.06
-0.11%
5.07
+3599.89%
0.14
0.00
Net Debt
0.40
—
—
—
Capital Lease Obligations
0.03
-61.04%
0.09
-35.10%
0.14
0.00
Net Tangible Assets
1.23
-50.11%
2.47
-57.98%
5.88
-46.98%
11.09
Tangible Book Value
1.23
-50.11%
2.47
-57.98%
5.88
-46.98%
11.09
Interest Payable
0.10
-5.01%
0.11
0.00
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-5.70
-43.46%
-3.97
+40.91%
-6.73
+16.79%
-8.08
Cash Flow From Continuing Operating Activities
-5.70
-43.46%
-3.97
+40.91%
-6.73
+16.79%
-8.08
Net Income From Continuing Operations
-7.36
-26.78%
-5.81
+14.51%
-6.80
+30.20%
-9.74
Other Non Cash Items
0.05
-22.73%
0.06
—
—
Stock Based Compensation
0.93
-17.41%
1.13
-9.47%
1.24
-34.14%
1.89
Operating Gains Losses
0.05
+222.09%
-0.04
+96.08%
-0.98
-2061.56%
0.05
Gain Loss On Investment Securities
—
—
—
—
Net Foreign Currency Exchange Gain Loss
0.05
+107.89%
0.02
-41.27%
0.04
-23.04%
0.05
Change In Working Capital
0.66
-12.42%
0.75
+626.87%
-0.14
+55.41%
-0.32
Change In Receivables
-0.86
-517.93%
0.21
+320.40%
-0.09
-97.41%
-0.05
Changes In Account Receivables
-0.85
-485.99%
0.22
+255.26%
-0.14
-69.74%
-0.08
Change In Prepaid Assets
0.08
+239.36%
0.02
-61.88%
0.06
+566.08%
-0.01
Change In Payables And Accrued Expense
0.54
+199.58%
0.18
+186.83%
-0.21
-7836.29%
-0.00
Change In Accrued Expense
0.22
-37.82%
0.36
-19.00%
0.44
+80.95%
0.25
Change In Payable
0.31
+274.52%
-0.18
+72.33%
-0.65
-162.43%
-0.25
Change In Account Payable
0.31
+274.52%
-0.18
+72.33%
-0.65
-162.43%
-0.25
Change In Other Working Capital
0.90
+159.94%
0.34
+275.19%
0.09
+135.70%
-0.26
Investing Cash Flow
0.08
+104.37%
-1.88
-125.18%
7.45
+414.44%
-2.37
Cash Flow From Continuing Investing Activities
0.08
+104.37%
-1.88
-125.18%
7.45
+414.44%
-2.37
Net Investment Purchase And Sale
0.08
+104.37%
-1.88
-125.18%
7.45
+414.44%
-2.37
Purchase Of Investment
-5.95
+18.94%
-7.34
-145.10%
-3.00
+69.64%
-9.87
Sale Of Investment
6.03
+10.38%
5.47
-47.66%
10.45
+39.28%
7.50
Gain Loss On Sale Of Business
0.00
+100.00%
-0.06
+94.01%
-1.02
0.00
Financing Cash Flow
4.96
-15.11%
5.85
0.00
-100.00%
0.54
Cash Flow From Continuing Financing Activities
4.96
-15.11%
5.85
0.00
-100.00%
0.54
Net Issuance Payments Of Debt
0.00
-100.00%
5.82
0.00
—
Issuance Of Debt
0.00
-100.00%
5.82
0.00
—
Long Term Debt Issuance
0.00
-100.00%
5.82
0.00
—
Net Long Term Debt Issuance
0.00
-100.00%
5.82
0.00
—
Net Common Stock Issuance
4.94
0.00
—
—
Proceeds From Stock Option Exercised
0.02
-0.01%
0.02
0.00
-100.00%
0.54
Changes In Cash
-0.66
-26297.74%
-0.00
-100.34%
0.72
+107.30%
-9.91
Effect Of Exchange Rate Changes
0.00
+133.49%
-0.01
-143.02%
-0.00
+94.67%
-0.04
Beginning Cash Position
6.51
-0.13%
6.52
+12.44%
5.79
-63.21%
15.75
End Cash Position
5.85
-10.04%
6.51
-0.13%
6.52
+12.44%
5.79
Free Cash Flow
-5.70
-43.46%
-3.97
+40.91%
-6.73
+16.79%
-8.08
Interest Paid Supplemental Data
0.41
+60.05%
0.26
0.00
—
Amortization Of Securities
-0.02
+65.99%
-0.07
-33.99%
-0.05
-256.95%
0.03
Change In Interest Payable
-0.01
-105.01%
0.11
0.00
—
Common Stock Issuance
4.94
0.00
—
—
Earnings Losses From Equity Investments
—
—
—
0.00
Issuance Of Capital Stock
4.94
0.00
—
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category